Hypermethylation of p15 Gene in Diffuse - Large B-Cell Lymphoma: Association with Less Aggressiveness of the Disease (original) (raw)

Abstract

Fift y-one patients (26 male, 25 female; median age 52.4 years, range 19-83 years) with DLBCL included in this study were diagnosed and treated in the

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (45)

  1. Gatter KC , Warnke RA . Diffuse large B-cell lymphoma . In: Jaffe E , Harris NL , Stein H , Vardiman JW , eds. World Health Organization Classifi cation of Tumours: Pathology and Genetics of Tu- mours of Haematopoietics and Lymphoid Tissues IARC Press, Lyon, 2001, pp, 171-174 .
  2. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma . N Engl J Med. 1993 ; 329 : 987 -994 .
  3. Armitage JO , Weisenburger DD . New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classifi cation Project . J Clin Oncol. 1998 ; 16 : 2780 -2795 .
  4. Alizadeh AA , Eisen MB , Davis RE , Ma C , Lossos IS , Rosenwald A , Boldrick JC , Sabet H , Tran T , Yu X , et al. Distinct types of diffuse large B-cell lymphoma identifi ed by gene expression profi ling . Nature. 2000 ; 403 : 503 -511 .
  5. Rosenwald A , Wright G , Chan WC , Connors JM , Campo E , Fisher RI , Gascoyne RD , Muller- Hermelink HK , Smeland EB , Giltnane JM , et al. The use of molecular profi ling to predict survival after chemotherapy for diffuse large B-cell lymphoma . N Engl J Med. 2002 ; 346 : 1937 -1947 .
  6. Staudt LM , Dave S. The biology of human lymphoid malignancies revealed by gene expression profi ling . Adv Immunol. 2005 ; 87 : 163 -208 .
  7. Sehn LH , Berry B , Chhanabhai M , Fitzgerald C , Gill K , Hoskins P , Klasa R , Savage KJ , Shenkier T , Sutherland J , et al. The revised International Prognostic Index (R-IPI) is a better predictor of out- come than the standard IPI for patients with diffuse large B-cell lymphomatreated with R-CHOP . Blood. 2007 ; 109 : 1857 -1861 .
  8. Herman JG , Baylin SB . Gene silencing in cancer in association with promoter hypermethylation . N Engl J Med. 2003 ; 349 : 2042 -2054 .
  9. Martinez-Delgado B , Robledo M , Arranz E , Osorio A , Garcia MJ , Echezarreta G , Rivas C , Benitez J . Hypermethylation of p15/ink4b/MTS2 gene is differentially implicated among non-Hodgkin's lymphoma . Leukemia. 1998 ; 12 : 937 -941 .
  10. Baur AS , Shaw P , Burri N , Delacrétaz F , Bosman FT , Chaubert P . Frequent methylation silencing of p15 INK4b (MTS2) and p16 INK4a (MTS1) in B-cell and T-cell lymphomas . Blood. 1999 ; 94 : 1773 -1781 .
  11. Rossi D , Capello D , Gloghini A , Franceschetti S , Paulli M , Bhatia K , Saglio G , Vitolo U , Pileri SA , Esteller M , et al. Aberrant promoter methylation of multiple genes throughout the clinico- pathologic spectrum of B-cell neoplasia . Haematologica. 2004 ; 89 : 154 -164 .
  12. Esteller M , Gaidano G , Goodman SN , Zagonel V , Capello D , Botto B , Rossi D , Gloghini A , Vitolo U , Carbone A , et al. Hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma . J Natl Cancer Inst . 2002 ; 94 : 26 -32 .
  13. Shiozawa E , Takimoto M , Makino R , Adachi D , Saito B , Yamochi-Oniyuka T , Yamochi T , Shimo- zuma J , Maeda T , Kohno Y , et al. Hypermethylation of CpG islands in p16 as a prognostic factor for diffuse large B-cell lymphoma in a high-risk group . Leuk Res . 2006 ; 30 : 859 -867 .
  14. Amara K , Trimeche M , Ziadi S , Laatiri A , Hachana M , Korbi S . Prognostic signifi cance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas . Ann Oncol . 2008 ; 19 : 1774 -1786 .
  15. Pegg AE . Repair of O(6)-alkylguanine by alkyltransferases . Mutat Res . 2000 ; 462 : 83 -100 .
  16. Ng MH . Death associated protein kinase: from regulation of apoptosis to tumor suppresive function and B cell malignancies . Apoptosis. 2002 ; 7 : 261 -270 .
  17. Cheson BD , Horning SJ , Coiffi er B , Shipp MA , Fisher RI , Connors JM , Lister TA , Vose J , Grillo- Lopez A , Hagenbeek A , et al. Report of an International Workshop to standardize response criteria for non-Hodgkin's lymphomas . J Clin Oncol . 1999 ; 17 : 1244 -1253 .
  18. Krtolica K , Krajnovic ´ M , Ušaj-Kneževic ´ S , Babic´ D , Jovanovic ´ D , Dimitrijevic ´ B . Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value . World J Gastroenterol . 2007 ; 13 : 1187 -1194 .
  19. Sambrook J , Fritsch EF , Maniatis T . Analysis and cloning of eukariotic genomic DNA. In: Ford N , Nolan C , Ferguson M , eds. Molecular Cloning. A Laboratory Manual . New York : Cold Spring Harbor Laboratory Press ; 1989 , pp, 16-19.
  20. Herman JG , Graff JR , Myohanen S , Nelkin BD , Baylin SB . Methylation-specifi c PCR: a novel PCR assay for methylation status of CpG islands . Proc Natl Acad Sci USA . 1996 ; 93 : 9821 -9826 .
  21. Esteller M , Hamilton SR , Burger PC , Baylin SB , Herman JG . Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia . Cancer Res . 1999 ; 59 : 793 -797 .
  22. Katzenellenbogen RA , Baylin SB , Herman JG . Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies . Blood. 1999 ; 93 : 4347 -4353 .
  23. Drexler HG . Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells . Leukemia. 1998 ; 12 : 845 -859 .
  24. Garcia MJ , Martinez-Delgado B , Cebrian A , Martinez A , Benitez J , Rivas C . Different incidence and pattern of p15INK4b and p16INK4a promoter region hypermethylation in Hodgkin's lympho- ma and CD30-positive non-Hodgkin lymphomas . Am J Pathol . 2002 ; 161 : 1007 -1013 .
  25. Sanchez-Beato M , Saez AI , Navas IC , Algara P , Sol Mateo M , Villuendas R , Camacho F , San- chez-Aguilera A , Sanchez E , Piris MA . Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27 . Am J Pathol . 2001 ; 159 : 205 -213 .
  26. Lee SM , Lee EJ , Ko YH , Lee SH , Maeng L , Kim KM . Prognostic signifi cance of O6-methylgua- nine DNA methyltransferase and p57 methylation in patients with diffuse large B-cell lymphoma . APMIS. 2009 ; 117 : 87 -94 .
  27. Jardin F , Jais JP , Molina TJ , Parmentier F , Picquenot JM , Ruminy P , Tilly H , Bastard C , Salles GA , Feugier P , et al. Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study . Blood. 2010 ; 116 : 1092 -1104 .
  28. Zainuddin N , Kanduri M , Berglund M , Lindell M , Amini RM , Roos G , Sundstrom C , Enblad G , Rosenquist R . Quantitative evaluation of p16 INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma . Leuk Res . 2011 ; 35 : 438 -443 .
  29. Perunic ˇic ´ Jovanovic ´ M , Jakovic ´ Lj , Bogdanovic ´ A , Markovic ´ O , C ˇemerikic ´ V , Mihaljevic ´c ´ B . Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl- 2 and Ki 67-positive tumor cells . Vojnosanit Pregl . 2009 ; 66 : 738 -743 .
  30. Wemmert S , Bettscheider M , Alt S , Ketter R , Kammers K , Feiden W , Steudel WI , Rahnenführer J , Urbschat S . p15 promoter methylation -a novel prognostic marker in glioblastoma patients . Int Journal Oncol . 2009 ; 34 : 1743 -1748 .
  31. Deneberg S , Grovdal M , Karimi M , Jansson M , Nahi H , Corbaciogly A , Gaidzik V , Dohner K , Paul C , Ekstrom TJ , et al. Gene-specifi c and global methylation patterns predict outcome in patients with acute myeloid leukemia . Leukemia. 2010 ; 24 : 932 -941 .
  32. Kim M , Oh B , Kim SY , Park HK , Hwang SM , Kim TY , She CJ , Yang I , Yoon SS , Yoon JH , et al. p15INK4b methylation correlates with t h rombocytopenia, blast percentage, and survival in mye- lodysplastic syndrome in a dose dependent manner: quantitation using pyrosequencing study . Leuk Res . 2010 ; 34 : 718 -722 .
  33. El-Maarri O , Becker T , Junen J , Manzoor SS , Diaz-Lacava A , Schwaab R , Wienker T , Olden- burg J . Gender specifi c differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males . Hum Genet. 2007 ; 122 : 505 -514 .
  34. Muller C , Murawski N , Wiesen MHJ , Held G , Poeschel V , Zeynalova S , Wenger M , Nickenig C , Peter N , Lengfelder E , et al. The role of gender and weight on rituximab clearance and serum elimination half life in elderly patients with DLBCL . Blood. 2012 ; 119: 3276 -3284 .
  35. Tagawa H , Suguro M , Tsuzuki S , Matsuo K , Karnan S , Ohshima K , Okamoto M , Morishima Y , Nakamura S , Seto M . Comparison of genome profi les for identifi cation of distinct subgroups of diffuse large B-cell lymphoma . Blood. 2005 ; 106 : 1770 -1777 .
  36. Lenz G , Wright GW , Emre NC , Kohlhammer H , Dave SS , Davis RE , Carty S , Lam LT , Shaffer AL , Xiao W , et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways . Proc Natl Acad Sci USA. 2008 ; 105 : 13520 -13525 .
  37. Guney S , Jardin F , Bertrand P , Mareschal S , Parmentier F , Picquenot JM , Tilly H , Bastard C . Several mechanisms lead to the inactivation of the CDKN2A (p16), p14ARF, or CDKN2B (p15) genes in the GCB and ABC molecular DLBCL subtypes . Genes Chromosomes Cancer. 2012 ; 51 : 858 -867 .
  38. Cameron EE , Baylin BS , Herman JG . p15 (INK4B) CpG island methylation in primary acute leukemia is heterogenous and suggests density as a critical factor for trancriptional silencing . Blood. 1999 ; 94 : 2445 -2451 .
  39. Gronbaek K , de Nully Brown P , Moller MB , Nedergaard T , Ralfkiaer E , Moller P , Zeuthen J , Guld- berg P . Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma . Leukemia. 2000 ; 14 : 1727 -1735 .
  40. Kraguljac N , Krajnovic ´ M , Dimitrijevic ´ B , Mihaljevic ´ B , Gotic´ M , Krtolica K . Frequency of aberrant promoter methylation of p15INK4B and O6-methylguanine-DNA methyltransferase genes in B- cell non-Hodgkin lymphoma: a pilot study . Arch Biol Sci. 2010 ; 62 : 211 -221 .
  41. Kim SS , Choi YH , Han CW , Choi YD , Park Y , Lee JJ , Kim HJ , Lee IK , Lee JS , Juhng SW , et al. DNA methylation profi les of MGMT, DAPK1, bhMLH1, CDH1, SHP1, and HIC1 in B-cell lymphomas . Korean J Pathol. 2009 ; 43 : 420 -427 .
  42. Lee GW , Kang JH , Kim IS , Kim HG , Ko GH , Lee JH , Kim DC , Song DH , Yang JW , Lee JS . Is inactivation of O 6 -methylguanine DNA methyltransferase still a favorable prognostic factor of pa- tients with diffuse large B-cell lymphoma in the era of R-CHOP chemotherapy? Leuk Lymphoma . 2009 ; 50 : 1992 -1998 .
  43. Voso MT , Gumiero D , D'Alo' F , Guidi F , Mansueto G , Di Febo AL , Massini G , Martini M , Larocca LM , Hohaus S , et al. DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma . Haematologica. 2006 ; 91 : 1252 -1256 .
  44. Cohen O , Kimchi A . DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer . Cell Death Differ. 2001 ; 8 : 6 -15 .
  45. Nakamichi I , Tomita Y , Zhang B , Sugiyama H , Kanakura Y , Fukuhara S , Hino M , Knamaru A , Ogawa H , Aozasa K . Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma . Ann Hematol. 2007 ; 86 : 557 -564 .